137 results on '"Rosa, Gennaro"'
Search Results
2. Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
3. 349 INTRAVENOUS CANGRELOR INFUSION IN PATIENTS UNDERGOING COMPLEX VERSUS NON-COMPLEX PERCUTANEOUS CORONARY INTERVENTION: A SUBANALYSIS OF THE ICARUS REGISTRY
4. 330 INTRAVENOUS CANGRELOR INFUSION IN HIGH BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: PRELIMINARY RESULTS OF THE ICARUS REGISTRY
5. 910 PREVALENCE AND PROGNOSTIC IMPACT OF ANAEMIA IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION AND RECEIVING CANGRELOR: A SUBANALYSIS OF THE ICARUS REGISTRY
6. 345 INTRAVENOUS CANGRELOR INFUSION IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SUBANALYSIS OF THE ICARUS REGISTRY
7. 902 INCIDENCE, CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS PRESENTING WITH VERSUS WITHOUT CARDIOGENIC SHOCK AND RECEIVING CANGRELOR: AN EXPLORATORY SUBANALYSIS OF THE ICARUS REGISTRY
8. Uric Acid induces a pro-atherothrombotic phenotype in human endothelial cells by imbalancing TF/TFPI pathway
9. Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway
10. Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway.
11. Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection?
12. Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
13. Surgical excision of developmental retrorectal cysts: results with long-term follow-up from a single institution
14. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells
15. Estrogen–progestogen induced hematocolpometra following allogeneic stem cell transplant
16. Endocrine disorders during the first year after autologous stem-cell transplant
17. Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.
18. Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies
19. Long-Lasting Bone Damage Detected by Dual-Energy X-Ray Absorptiometry, Phalangeal Osteosonogrammetry, and in Vitro Growth of Marrow Stromal Cells after Allogeneic Stem Cell Transplantation
20. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation
21. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases
22. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
23. Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia[colon] a pilot study from the Gimema Group
24. THIOTEPA-BASED Vs TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT
25. THIOTEPA-BASED HIGH-DOSE PREPARATION Vs BEAM FOR AUTOLOGOUS HEMOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN LYMPHOMA OTHER THAN PCNSL: A RETROSPECTIVE UPDATE FROM THE EBMT
26. THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA
27. XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION
28. THIOTEPA-BASED Vs TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF EBMT
29. PEG-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION : A SINGLE-CENTRE EXPERIENCE
30. CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT
31. ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY
32. WHAT IS THE BEST CONDITIONING FOR AUTO-TRANSPLANT IN AML PATIENTS?
33. Transient and persistent endocrine disorders in autologous stem cell transplanted patients
34. Mobilization of peripheral blood hematopoietic stem cells by granulocyte-colony stimulating factor and plerixafor in patients with cardiac AL amyloidosis
35. Estrogen-progestogen induced hematocolpometra following allogenic stem cell transplant
36. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
37. Early hematopoietic zinc finger protein (EHZF), the human homologue to mouse Evi3, is highly expressed in primitive human hematopoietic cells
38. Accelerated bone mass senescence after hematopoietic stem cell transplantation
39. Avid (67)Ga uptake in multiple myeloma relapsing after bone marrow transplant
40. Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma
41. THERAPEUTIC OPTIONS IN ACUTE LEUKEMIAS
42. Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT
43. Un caso di carcinoma midollare della tiroide con metastasi linfonodali a differenziazione divergente
44. Cystic lymphangioma of the transverso mesocolon miming a pancreatic neoplasm
45. Circulating Megakaryocyte-Derived Cells Detected by Flow Cytometry As Marker of Aggressive Neoplasms of Megakaryocytic Lineage in Acute Megakaryoblastic Leukemia and Allied Malignancies Presenting As Primary Myelofibrosis
46. Estrogen-progestin therapy in women after stem cell transplant
47. Clinical Relevance of Intrahepatic Hepatitis B Virus DNA in HBsAg-negative HBcAb-positive Patients Undergoing Hematopoietic Stem Cell Transplantation for Hematological Malignancies
48. Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma
49. High Serum Leptin in Patients with Chronic Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation
50. Long-Lasting Bone Damage Detected by Dual-Energy X-Ray Absorptiometry, Phalangeal Osteosonogrammetry, andin VitroGrowth of Marrow Stromal Cells after Allogeneic Stem Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.